JCPSLP
Volume 16, Number 2 2014
95
ischaemic stroke: An updated systematic review and meta-
analysis.
Lancet
,
379
, 2364–2372.
Wentworth, D. A., & Atkinson., R. P. (1996). Implementation
of an acute stroke program decreases hospitalization costs
and length of stay.
Stroke
,
6
, 1040–1043.
Whelan, K. (2001). Inadequate fluid intakes in dysphagic
acute stroke.
Clinical Nutrition
,
20
(5), 423–428.
Yamaguchi, T., Minematsu, K., & Hasegawa, Y. (1997).
General care in acute stroke.
Cerebrovascular Disease
,
7
,
12–17.
Yasaka, M., Yamauchi, T., Oita, J., Sawada, T., Shichiri,
M., & Omae, T. (1993). Clinical features of recurrent
embolisation in acute cardioembolic stroke,
Stroke
,
24
(11),
1681–1685.
from the Safe Implementation of Thrombolysis in Stroke
registry (2002–2008).
Medical Journal of Australia
,
193
(8),
439–443.
Smithard, D., O’Neill, P., Park, C., Morris, J., Wyatt,
R., England, R., & Martin, D. (1996). Complications and
outcome after acute stroke: Does dysphagia matter?
Stroke
,
27
, 1200–1204.
Sung, S. F., Ong, C. T., Wu, C. S., Hsu, Y. C., & Su,
Y. H. (2010). Increased use of thrombolytic therapy and
shortening of in-hospital delays following acute ischemic
stroke: Experience on the establishment of a primary stroke
center at a community hospital.
Acta Neurologica Taiwania
.
19
(4), 246–52.
Sutherland, J. M., Hamm, J., & Hatcher, J. (2010). A
general method for adjusting case mix payment amounts
for inaccurately reported clinical data.
Health Care
Management Science
,
13
(1), 65–73.
Wardlaw, J. M., Koumellis, P., & Liu. (2013). Thrombolysis
(different doses, routs of administration and agents) for
acute ischaemic stroke.
Cochrane Database of Systematic
Reviews
. Issue 5.
Wardlaw, J. M., Murray, V., Berge, D., & del Zoppo, G. J.
(2009). Thrombolysis for acute ischaemic stroke.
Cochrane
Database of Systematic Reviews
, Issue 4.
Wardlaw, J. M., Murray, V., Berge, D., & del Zoppo, G.
J. (2010). Thrombolysis for acute ischaemic stroke.
Stroke
,
41
, 445–446.
Wardlaw, J. M., Murray, V., Berge, D., del Zoppo, G.
J., Sandercock, P., Lindley, R. L., & Cohen, G. (2012).
Recombinant tissue plasminogen activator for acute
Jennifer Davis
is a senior speech pathologist at Logan Hospital
and has a wide range of clinical experience over many years, most
recently specialising in the acute management of Dysphagia.
Anne Coccetti
is the Director of Speech Pathology at the Logan
Hospital and has many years of clinical experience working with
swallowing in acute and rehabilitation settings, and in establishing
and managing new services.
Elizabeth Cardell
is Head of Speech
Pathology at Griffith University.
Correspondence to:
Jennifer Davis
Senior Speech Pathologist
Metro South Hospital and Health Service
Queensland Health
email:
